FTC targets transgender health advocacy amid systemic healthcare inequities and corporate capture of medical standards
Original framing: “Federal Trade Commission sues leading transgender health group - AP News” — AP News (via Google News)
Trans communities of color, who face the highest barriers to care, are disproportionately affected by this lawsuit, as it threatens the very organizations they rely on. The framing ignores the voices of Black and Indigenous trans women who have led grassroots health initiatives for decades. Mainstream coverage centers institutional actors (FTC, AP News) while erasing the lived experiences of those most impacted by the lawsuit.
The FTC's lawsuit against a leading transgender health group is not an isolated legal action but a symptom of a global neoliberal project that pathologizes gender diversity while privatizing healthcare.
This case mirrors historical patterns of medical control over marginalized bodies, from the DSM's classification of homosexuality to the forced sterilization of trans people, now repackaged as 'antitrust enforcement.' The framing serves corporate healthcare actors by obscuring their role in creating healthcare inequities, while delegitimizing trans-led solutions that operate outside biomedical gatekeeping. Indigenous and non-Western frameworks offer a radical alternative, treating gender diversity as a natural variation rather than a condition to be policed. The solution lies in dismantling the colonial biomedical monopoly, centering community-controlled care, and re-educating regulators to recognize the legitimacy of marginalized knowledge systems. Without this, the FTC's action will further entrench a healthcare system that treats trans lives as commodities to be controlled, not humans to be healed.